Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$93.32

4.43 (4.98%)

05:01
07/25/18
07/25
05:01
07/25/18
05:01

Eli Lilly downgraded to Hold from Buy at Berenberg

  • 10

    Sep

LLY Eli Lilly
$93.32

4.43 (4.98%)

07/17/18
CANT
07/17/18
NO CHANGE
CANT
Overweight
Aclaris offers best risk/reward of hair loss players, says Cantor Fitzgerald
The potential for JAK inhibitors to treat alopecia areata may be underappreciated by investors because the Street does not appear to be ascribing enough value to the opportunity, Cantor Fitzgerald analyst Louise Chen tells investors in a research note. Of the three companies she covers developing JAKs for hair loss, Aclaris Therapeutics (ACRS), Eli Lilly (LLY) and Pfizer (PFE), the analyst believes Aclaris offers the best risk/reward and greatest upside potential. The company has a market cap below $700M and two potential "shots on goal" for alopecia areata, Chen writes. She estimates combined peak sales of $1B-plus for both opportunities and keeps an Overweight rating on Aclaris. The physicians the analyst spoke to believe the company's JAKs for hair loss will work.
07/18/18
PIPR
07/18/18
NO CHANGE
Target $450
PIPR
Overweight
Piper maintains Overweight on Regeneron on tanezumab news
Piper Jaffray analyst Christopher Raymond keeps an Overweight rating on Regeneron Pharmaceuticals (REGN) on news that tanezumab, Pfizer (PFE) and Eli Lilly's (LLY) anti-NGF antibody that is a competitor to Regeneron's fasinumab, successfully completed the first of several Phase 3 trials. Fasinumab remains an unmodeled opportunity, but the read-through from tanezumab is positive and the market for an effective, non-opioid chronic pain treatment is "massive," Raymond tells investors in a research note. The analyst points out that Regeneron and Teva (TEVA) still expect to report Phase 3 data starting later this year. Raymond keeps an Overweight rating on Regeneron with a $450 price target.
07/18/18
WELS
07/18/18
NO CHANGE
WELS
Novartis report has negative read through for Teva, Mylan, says Wells Fargo
Wells Fargo analyst David Maris noted that Novartis (NVS) lowered its 2018 guidance for Sandoz along with its Q2 report and reportedly told Bloomberg that it would consider selling the generic drug unit. He sees a negative read through for companies with large U.S. commodity generic exposure, such as Teva (TEVA) and Mylan (MYL), from Novartis' report, Maris tells investors. He also noted that Novartis said it will not increase prices on its drugs in the U.S. for the rest of 2018, as Pfizer (PFE) recently has also said, calling this "a wise approach and correct read of the increasing intensity of the scrutiny around rising healthcare costs." Maris continues to expect the " chilling effect" on price increases to spread through the industry. Lastly, the analyst pointed out that the Amgen-partnered (AMGN) launch of Aimovig is off to a strong start, which he believes bodes well for Teva's fremanezumab and Eli Lilly's (LLY) galcanezumab.
07/19/18
BMOC
07/19/18
NO CHANGE
Target $80
BMOC
Market Perform
Eli Lilly to have a 'good Q2' on beats from launch franchises, says BMO Capital
BMO Capital analyst Alex Arfaei raised his price target on Eli Lilly to $80 from $78 ahead of its Q2 earnings, saying the company will have a "good" quarter on "beats from its launch franchises Trulicity, Jardiance, and Basaglar". The analyst also keeps his Market Perform rating, adding that while the the pipeline potential of its Galcanezumab and Tanezumab drugs is promising, he believes investors are underappreciating the headwinds around its diabetes program. He see higher risks of an increased biosimilar erosion for Humalog from Sanofi's (SNY) Admelog, and Trulicity competitive pressure from Novo's (NVO) Ozempic in 2019.

TODAY'S FREE FLY STORIES

RACE

Ferrari

$168.55

2.05 (1.23%)

21:17
07/15/19
07/15
21:17
07/15/19
21:17
Recommendations
Ferrari analyst commentary at Goldman Sachs »

Ferrari price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNLSY

Renault

$0.00

(0.00%)

21:12
07/15/19
07/15
21:12
07/15/19
21:12
Initiation
Renault initiated at Goldman Sachs »

Renault initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PUGOY

Peugeot

$0.00

(0.00%)

21:07
07/15/19
07/15
21:07
07/15/19
21:07
Initiation
Peugeot initiated at Goldman Sachs »

Peugeot initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTES

NetEase

$256.35

-3.62 (-1.39%)

21:02
07/15/19
07/15
21:02
07/15/19
21:02
Hot Stocks
NetEase acquires minority stake in Behaviour Interactive, terms not stated »

NetEase Games announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$14.18

0.045 (0.32%)

20:57
07/15/19
07/15
20:57
07/15/19
20:57
Initiation
Fiat Chrysler initiated at Goldman Sachs »

Fiat Chrysler initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

DDAIF

Daimler AG

$0.00

(0.00%)

20:53
07/15/19
07/15
20:53
07/15/19
20:53
Initiation
Daimler AG initiated at Goldman Sachs »

Daimler AG initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMWYY

BMW

$0.00

(0.00%)

20:48
07/15/19
07/15
20:48
07/15/19
20:48
Initiation
BMW initiated at Goldman Sachs »

BMW initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALE

Vale

$13.99

0.175 (1.27%)

20:38
07/15/19
07/15
20:38
07/15/19
20:38
Periodicals
Vale to pay $106.5M to Brazil workers impacted by dam incident, Reuters says »

Vale disclosed that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

RNR

RenaissanceRe

$187.35

3.295 (1.79%)

20:36
07/15/19
07/15
20:36
07/15/19
20:36
Downgrade
RenaissanceRe rating change at Deutsche Bank »

RenaissanceRe downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

JPM

JPMorgan

$113.87

-1.45 (-1.26%)

, JNJ

Johnson & Johnson

$134.67

0.38 (0.28%)

20:25
07/15/19
07/15
20:25
07/15/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

JPM

JPMorgan

$113.87

-1.45 (-1.26%)

JNJ

Johnson & Johnson

$134.67

0.38 (0.28%)

WFC

Wells Fargo

$46.70

-0.65 (-1.37%)

GS

Goldman Sachs

$211.55

-2.4 (-1.12%)

PLD

Prologis

$79.94

-0.09 (-0.11%)

FRC

First Republic

$98.61

-2.02 (-2.01%)

DPZ

Domino's Pizza

$269.97

-12.26 (-4.34%)

SNV

Synovus

$34.35

-1.08 (-3.05%)

FHN

First Horizon

$14.80

-0.305 (-2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 29

    Jul

  • 30

    Jul

  • 06

    Aug

  • 27

    Aug

  • 28

    Aug

  • 06

    Sep

  • 09

    Sep

  • 16

    Sep

  • 23

    Sep

  • 12

    Oct

  • 13

    Nov

SON

Sonoco

$64.49

-0.69 (-1.06%)

20:04
07/15/19
07/15
20:04
07/15/19
20:04
Downgrade
Sonoco rating change at BMO Capital »

Sonoco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

  • 17

    Oct

SON

Sonoco

$64.49

-0.69 (-1.06%)

19:59
07/15/19
07/15
19:59
07/15/19
19:59
Downgrade
Sonoco rating change at BMO Capital »

Sonoco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

  • 17

    Oct

PLD

Prologis

$79.94

-0.09 (-0.11%)

19:51
07/15/19
07/15
19:51
07/15/19
19:51
Hot Stocks
Prologis to buy Black Creek Group industrial RE investment platform for $3.99B »

Black Creek Group has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

PLD

Prologis

$79.94

-0.09 (-0.11%)

19:48
07/15/19
07/15
19:48
07/15/19
19:48
Earnings
Prologis reports Q2 FFO 77c, consensus 76c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

CVX

Chevron

$125.71

-0.27 (-0.21%)

19:46
07/15/19
07/15
19:46
07/15/19
19:46
Hot Stocks
Chevron ordered to stop oil spill in California by State Regulator »

California Natural…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

GPL

Great Panther Silver

$0.72

-0.0409 (-5.38%)

19:33
07/15/19
07/15
19:33
07/15/19
19:33
Hot Stocks
Great Panther Silver names Jeffrey Mason as new board chair »

Great Panther Silver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$120.88

0.77 (0.64%)

19:04
07/15/19
07/15
19:04
07/15/19
19:04
Hot Stocks
PayPal launches international money transfer service Xoom »

PayPal launched Xoom-its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

JBHT

J.B. Hunt

$92.50

-0.45 (-0.48%)

, EYEN

Eyenovia

$2.89

0.04 (1.40%)

18:58
07/15/19
07/15
18:58
07/15/19
18:58
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: JB…

JBHT

J.B. Hunt

$92.50

-0.45 (-0.48%)

EYEN

Eyenovia

$2.89

0.04 (1.40%)

VKTX

Viking Therapeutics

$8.25

0.02 (0.24%)

ARW

Arrow Electronics

$68.82

-0.15 (-0.22%)

ATEX

Anterix

$47.61

0.61 (1.30%)

RGEN

Repligen

$85.87

0.86 (1.01%)

MPW

Medical Properties Trust

$18.28

-0.23 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

  • 24

    Jul

  • 25

    Jul

  • 06

    Aug

  • 08

    Aug

  • 09

    Aug

  • 26

    Aug

  • 09

    Sep

  • 18

    Sep

  • 19

    Sep

  • 13

    Nov

  • 16

    Jul

  • 17

    Jul

  • 17

    Jul

WTFC

Wintrust Financial

$69.99

-2.05 (-2.85%)

18:56
07/15/19
07/15
18:56
07/15/19
18:56
Earnings
Wintrust Financial reports Q2 EPS $1.38, consensus $1.66 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 06

    Aug

DDAIF

Daimler AG

$0.00

(0.00%)

18:46
07/15/19
07/15
18:46
07/15/19
18:46
Initiation
Daimler AG initiated at Goldman Sachs »

Daimler AG initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PUGOY

Peugeot

$0.00

(0.00%)

18:46
07/15/19
07/15
18:46
07/15/19
18:46
Initiation
Peugeot initiated at Goldman Sachs »

Peugeot initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$14.18

0.045 (0.32%)

18:45
07/15/19
07/15
18:45
07/15/19
18:45
Initiation
Fiat Chrysler initiated at Goldman Sachs »

Fiat Chrysler initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

TGI

Triumph Group

$23.07

-0.22 (-0.94%)

18:42
07/15/19
07/15
18:42
07/15/19
18:42
Hot Stocks
Triumph Group selected by leading airline as MRO provider »

Triumph Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 31

    Jul

TRQ

Turquoise Hill

$1.07

-0.02 (-1.83%)

18:32
07/15/19
07/15
18:32
07/15/19
18:32
Hot Stocks
Turquoise Hill reports Q2 copper output 39.2KT, down 0.6% from last year »

Reports Q2 Gold output…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIO

Rio Tinto

$61.50

0.77 (1.27%)

18:29
07/15/19
07/15
18:29
07/15/19
18:29
Hot Stocks
Rio Tinto cuts FY19 Pilbara ore shipments view to 320M-330M tons »

Prior view was 333M-343M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.